Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET
Journal of Nuclear Medicine · 2023
DOI: 10.2967/jnumed.122.264864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Marcelo F Di Carli. Beteiligte Einrichtung: Cardiovascular Imaging Program, Departments of Radiology and Medicine; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology; a…. Hauptthemen laut MEDLINE: Myocardial Perfusion Imaging, Coronary Artery Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Over the past half century, radionuclide myocardial perfusion imaging (MPI) has played a transformative role in the evaluation of patients with suspected or known coronary artery disease (CAD). The quantification of the burden of myocardial ischemia and scarring has played a critical role in the
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cardiovascular Imaging Program, Departments of Radiology and Medicine; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology; and Division of Cardiovascular Medicine, Department of Medicine, Brigha…
Förderung
- NHLBI NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Di Carli, M. F. (2023). Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.264864
Vancouver
Di Carli MF. Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.264864
BibTeX
@article{DiCarli2023,
author = {Di Carli, Marcelo F},
title = {Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET},
journal = {Journal of Nuclear Medicine},
year = {2023},
doi = {10.2967/jnumed.122.264864}
}
EUVIMED